Evidence  ||| S:0 E:9 ||| NN
of  ||| S:9 E:12 ||| IN
prophylaxis  ||| S:12 E:24 ||| JJ
treatment  ||| S:24 E:34 ||| NN
in  ||| S:34 E:37 ||| IN
adult  ||| S:37 E:43 ||| NN
haemophiliacs ||| S:43 E:56 ||| NN
.  ||| S:56 E:58 ||| .
Need  ||| S:58 E:63 ||| NN
of  ||| S:63 E:66 ||| IN
this  ||| S:66 E:71 ||| DT
treatment  ||| S:71 E:81 ||| NN
strategy ||| S:81 E:89 ||| NN
?  ||| S:89 E:91 ||| .
In  ||| S:91 E:94 ||| IN
contrast  ||| S:94 E:103 ||| NN
to  ||| S:103 E:106 ||| TO
children  ||| S:106 E:115 ||| NNS
with  ||| S:115 E:120 ||| IN
haemophilia  ||| S:120 E:132 ||| VBG
the  ||| S:132 E:136 ||| DT
scientific  ||| S:136 E:147 ||| JJ
evidence  ||| S:147 E:156 ||| NN
of  ||| S:156 E:159 ||| IN
prophylaxis  ||| S:159 E:171 ||| JJ
treatment  ||| S:171 E:181 ||| NN
in  ||| S:181 E:184 ||| IN
adults  ||| S:184 E:191 ||| NNS
is  ||| S:191 E:194 ||| VBZ
not  ||| S:194 E:198 ||| RB
yet  ||| S:198 E:202 ||| RB
proven ||| S:202 E:208 ||| VBN
.  ||| S:208 E:210 ||| .
Existing  ||| S:210 E:219 ||| VBG
studies  ||| S:219 E:227 ||| NNS
are  ||| S:227 E:231 ||| VBP
of  ||| S:231 E:234 ||| IN
observational  ||| S:234 E:248 ||| JJ
character  ||| S:248 E:258 ||| NN
and  ||| S:258 E:262 ||| CC
mostly  ||| S:262 E:269 ||| RB
retrospectively  ||| S:269 E:285 ||| VB
designed ||| S:285 E:293 ||| VBN
.  ||| S:293 E:295 ||| .
Therefore ||| S:295 E:304 ||| RB
,  ||| S:304 E:306 ||| ,
opinion  ||| S:306 E:314 ||| NN
leaders  ||| S:314 E:322 ||| NNS
in  ||| S:322 E:325 ||| IN
this  ||| S:325 E:330 ||| DT
field  ||| S:330 E:336 ||| NN
postulate  ||| S:336 E:346 ||| VBZ
prospectively  ||| S:346 E:360 ||| RB
designed ||| S:360 E:368 ||| VBN
,  ||| S:368 E:370 ||| ,
randomized ||| S:370 E:380 ||| NN
,  ||| S:380 E:382 ||| ,
controlled  ||| S:382 E:393 ||| VBN
and  ||| S:393 E:397 ||| CC
multicentric  ||| S:397 E:410 ||| JJ
studies  ||| S:410 E:418 ||| NNS
to  ||| S:418 E:421 ||| TO
set  ||| S:421 E:425 ||| VB
up  ||| S:425 E:428 ||| RP
urgently  ||| S:428 E:437 ||| RB
needed  ||| S:437 E:444 ||| VBN
guidelines ||| S:444 E:454 ||| NNS
.  ||| S:454 E:456 ||| .
Evidence  ||| S:456 E:465 ||| NN
according  ||| S:465 E:475 ||| VBG
to  ||| S:475 E:478 ||| TO
the  ||| S:478 E:482 ||| DT
Canadian  ||| S:482 E:491 ||| JJ
task  ||| S:491 E:496 ||| NN
force  ||| S:496 E:502 ||| NN
ranking  ||| S:502 E:510 ||| NN
is  ||| S:510 E:513 ||| VBZ
assessed  ||| S:513 E:522 ||| VBN
as  ||| S:522 E:525 ||| IN
level  ||| S:525 E:531 ||| NN
III  ||| S:531 E:535 ||| NNP
with  ||| S:535 E:540 ||| IN
a  ||| S:540 E:542 ||| DT
recommendation  ||| S:542 E:557 ||| NN
grade  ||| S:557 E:563 ||| NN
C  ||| S:563 E:565 ||| NNP
by  ||| S:565 E:568 ||| IN
the  ||| S:568 E:572 ||| DT
authors ||| S:572 E:579 ||| NNS
.  ||| S:579 E:581 ||| .
The  ||| S:581 E:585 ||| DT
recognition  ||| S:585 E:597 ||| NN
of  ||| S:597 E:600 ||| IN
benefits  ||| S:600 E:609 ||| NNS
of  ||| S:609 E:612 ||| IN
health  ||| S:612 E:619 ||| NN
care  ||| S:619 E:624 ||| NN
providers  ||| S:624 E:634 ||| NNS
in  ||| S:634 E:637 ||| IN
accordance  ||| S:637 E:648 ||| NN
with  ||| S:648 E:653 ||| IN
the  ||| S:653 E:657 ||| DT
German  ||| S:657 E:664 ||| JJ
Federal  ||| S:664 E:672 ||| NNP
Joint  ||| S:672 E:678 ||| NNP
Committee  ||| S:678 E:688 ||| NNP
generally  ||| S:688 E:698 ||| RB
demands  ||| S:698 E:706 ||| VBZ
a  ||| S:706 E:708 ||| DT
Grade-Ia  ||| S:708 E:717 ||| JJ
to  ||| S:717 E:720 ||| TO
Ib  ||| S:720 E:723 ||| NNP
evidence ||| S:723 E:731 ||| NN
.  ||| S:731 E:733 ||| .
As  ||| S:733 E:736 ||| IN
long  ||| S:736 E:741 ||| JJ
as  ||| S:741 E:744 ||| IN
the  ||| S:744 E:748 ||| DT
actual  ||| S:748 E:755 ||| JJ
evidence  ||| S:755 E:764 ||| NN
of  ||| S:764 E:767 ||| IN
prophylaxis  ||| S:767 E:779 ||| NN
in  ||| S:779 E:782 ||| IN
adult  ||| S:782 E:788 ||| NN
haemophiliacs  ||| S:788 E:802 ||| NN
does  ||| S:802 E:807 ||| VBZ
not  ||| S:807 E:811 ||| RB
meet  ||| S:811 E:816 ||| VB
the  ||| S:816 E:820 ||| DT
postulated  ||| S:820 E:831 ||| JJ
criteria  ||| S:831 E:840 ||| NNS
of  ||| S:840 E:843 ||| IN
the  ||| S:843 E:847 ||| DT
German  ||| S:847 E:854 ||| JJ
Federal  ||| S:854 E:862 ||| NNP
Joint  ||| S:862 E:868 ||| NNP
Committee ||| S:868 E:877 ||| NNP
,  ||| S:877 E:879 ||| ,
prophylactic  ||| S:879 E:892 ||| JJ
replacement  ||| S:892 E:904 ||| NN
therapy  ||| S:904 E:912 ||| NN
of  ||| S:912 E:915 ||| IN
the  ||| S:915 E:919 ||| DT
individual  ||| S:919 E:930 ||| JJ
case  ||| S:930 E:935 ||| NN
has  ||| S:935 E:939 ||| VBZ
to  ||| S:939 E:942 ||| TO
be  ||| S:942 E:945 ||| VB
well  ||| S:945 E:950 ||| RB
documented  ||| S:950 E:961 ||| VBN
and  ||| S:961 E:965 ||| CC
reasonably  ||| S:965 E:976 ||| RB
explained ||| S:976 E:985 ||| VBD
.  ||| S:985 E:987 ||| .
